Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04343443

Acute Heart Failure With Reduced Ejection Fraction - COngestion Discharge Evaluation

Acute Heart Failure With Reduced Ejection Fraction - COngestion Discharge Evaluation: Evaluation de la Congestion à la Sortie d'Hospitalisation Pour Insuffisance Cardiaque aiguë à Fraction d'éjection altérée ou modérément altérée

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The AHF-CODE reduced study is a prospective, non-randomized, monocenter study performed in patients with heart failure with reduced ejection fraction admitted for worsening heart failure. The main objective of the AHF-CODE study is to identify congestion markers (clinical, biological and ultrasound) at the end of hospitalization for acute heart failure that are associated with the risk of all cause death or rehospitalization for acute heart failure within 3 months of hospital discharge.

Conditions

Interventions

TypeNameDescription
PROCEDUREClinical examination centered on congestionClinical examination centered on congestion (ASCEND, NYHA and Ambrosy Score) will be performed before discharge from hospital
PROCEDURECardio-pulmonary, peritoneal, jugular and renal Doppler ultrasounds and liver elastographyCardio-pulmonary, peritoneal, jugular and renal Doppler ultrasounds and liver elastography will be performed before discharge from hospital
PROCEDUREBiological: Blood sample retrieved for biological assessment and biobankingBlood sample collection will be performed before discharge from hospital
PROCEDURETelephone interviewTelephone interview will be performed at 3, 12 months and 24 months after discharge from hospital
BEHAVIORALKansas City Cardiomyopathy Questionnaire (KCCQ)Questionnaire centered on patient's quality of life at discharge and 3, 12 and 24 months after discharge

Timeline

Start date
2020-08-21
Primary completion
2026-08-21
Completion
2028-08-21
First posted
2020-04-13
Last updated
2023-06-05

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04343443. Inclusion in this directory is not an endorsement.